Related Experiment Videos
[Specific dermatoses of pregnancy].
1Service de dermatologie, hôpital Fournier, 36, quai de la Bataille, 54035 Nancy. jl.schmutz@chu-nancy.fr
Presse Medicale (Paris, France : 1983)
|December 10, 2003
Summary
Pregnancy dermatoses, while often benign, require management due to potential maternal or fetal risks. Conditions like intra-hepatic cholestasis of pregnancy and pemphigoid gestationis necessitate specific treatments to ensure favorable outcomes.
Area of Science:
- Dermatology
- Obstetrics
- Immunology
Context:
- Pregnancy-specific dermatoses encompass a spectrum of conditions.
- While often benign, some pose risks to maternal or fetal well-being.
- These conditions require careful diagnosis and management.
Purpose:
- To review pregnancy-associated dermatoses.
- To highlight conditions requiring specific management due to potential complications.
- To discuss treatment modalities for various pregnancy dermatoses.
Summary:
- Intra-hepatic cholestasis of pregnancy (ICP) affects 1-2% of pregnant women, risking fetal growth delay, prematurity, or demise; treated with cholestyramine.
- Pemphigoid gestationis (PG) is an autoimmune disease managed with corticosteroids, typically resolving postpartum but with high relapse rates in subsequent pregnancies.
- Polymorphic dermatitis of pregnancy and impetigo herpetiformis are rarer conditions with variable presentations and outcomes, often requiring supportive care.
Impact:
- Provides a comprehensive overview of pregnancy dermatoses for clinicians.
- Emphasizes the importance of recognizing and managing conditions with potential fetal implications.
- Informs treatment strategies for conditions like ICP and PG, improving maternal and fetal outcomes.